Jiangxi Synergy Pharmaceutical Co., Ltd.

SZSE:300636 Stock Report

Market Cap: CN¥4.3b

Jiangxi Synergy Pharmaceutical Future Growth

Future criteria checks 5/6

Jiangxi Synergy Pharmaceutical is forecast to grow earnings and revenue by 28.8% and 29.2% per annum respectively while EPS is expected to grow by 26.1% per annum.

Key information

28.8%

Earnings growth rate

26.1%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate29.2%
Future return on equityn/a
Analyst coverage

Low

Last updated02 Apr 2024

Recent future growth updates

No updates

Recent updates

Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

May 01
Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Apr 27
Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Earnings and Revenue Growth Forecasts

SZSE:300636 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,198191N/A2832
12/31/2024954141N/A2422
3/31/2024708116-40108N/A
12/31/2023722106-51164N/A
9/30/2023751105-70160N/A
6/30/2023766115-51211N/A
3/31/2023761107-114185N/A
1/1/2023720101-115196N/A
9/30/202269289-171172N/A
6/30/202265181-189193N/A
3/31/202263588-219206N/A
12/31/202159281-293131N/A
9/30/202152476-312109N/A
6/30/202147671-29073N/A
3/31/202147674-22689N/A
12/31/202043570-15080N/A
9/30/202047167-12454N/A
6/30/202045563-12823N/A
3/31/202042860-1394N/A
12/31/201941348-213-28N/A
9/30/201936140-1895N/A
6/30/201933632-19533N/A
3/31/201927723-20737N/A
12/31/201826725-16775N/A
9/30/201826239-17969N/A
6/30/201827051-11795N/A
3/31/201830358-10558N/A
12/31/201729765N/A34N/A
9/30/201729875N/A52N/A
6/30/201728265N/A26N/A
3/31/201725757N/A28N/A
12/31/201625058N/A60N/A
9/30/201624852N/A57N/A
6/30/201626861N/A69N/A
3/31/201626963N/A90N/A
12/31/201527563N/A79N/A
12/31/201421339N/A65N/A
12/31/201314217N/A14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300636's forecast earnings growth (28.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 300636's earnings (28.8% per year) are forecast to grow faster than the CN market (23.3% per year).

High Growth Earnings: 300636's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300636's revenue (29.2% per year) is forecast to grow faster than the CN market (14% per year).

High Growth Revenue: 300636's revenue (29.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300636's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.